ZP4207(Dasiglucagon) Administered to T1D Patients to Assess the PK and PD Compared to Marketed Glucagon
Clinical trial NCT02916251 · COMPLETED
Trial details
- NCT number
- NCT02916251
- Sponsor
- Zealand Pharma
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-01
- Primary completion
- 2017-04-05
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.